iSpecimen Inc. Revenue Breakdown
No Revenue Breakdown for ISPC on this site yet.
- 2025-12-31: Others Not split by product in the filing$1.93M100.00%; Total revenue $1.93M.
- 2024-12-31: Others Not split by product in the filing$9.29M100.00%; Total revenue $9.29M.
- 2023-12-31: Others Not split by product in the filing$9.93M100.00%; Total revenue $9.93M.
- 2022-12-31: Others Not split by product in the filing$10.40M100.00%; Total revenue $10.40M.
Source checked: the stored Revenue Breakdown page for ISPC.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $1.93M 100.00% | $1.93M |
| 2024-12-31 | Not split by product in the filing $9.29M 100.00% | $9.29M |
| 2023-12-31 | Not split by product in the filing $9.93M 100.00% | $9.93M |
| 2022-12-31 | Not split by product in the filing $10.40M 100.00% | $10.40M |
| 2021-12-31 | Not split by product in the filing $11.14M 100.00% | $11.14M |
| 2020-12-31 | Not split by product in the filing $8.18M 100.00% | $8.18M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $151.94K 100.00% | $151.94K |
| 2026-03-31 | Not split by product $156.01K 100.00% | $156.01K |
| 2025-12-31 | Not split by product $51.76K 100.00% | $51.76K |
| 2025-09-30 | Not split by product $106.59K 100.00% | $106.59K |
| 2025-06-30 | Not split by product $713.13K 100.00% | $713.13K |
| 2025-03-31 | Not split by product $1.06M 100.00% | $1.06M |
| 2024-12-31 | Not split by product $1.48M 100.00% | $1.48M |
| 2024-09-30 | Not split by product $2.66M 100.00% | $2.66M |
| 2024-06-30 | Not split by product $2.86M 100.00% | $2.86M |
| 2024-03-31 | Not split by product $2.29M 100.00% | $2.29M |
| 2023-12-31 | Not split by product $2.58M 100.00% | $2.58M |
| 2023-09-30 | Not split by product $2.78M 100.00% | $2.78M |
| 2023-06-30 | Not split by product $1.63M 100.00% | $1.63M |
| 2023-03-31 | Not split by product $2.95M 100.00% | $2.95M |
| 2022-12-31 | Not split by product $2.96M 100.00% | $2.96M |
| 2022-09-30 | Not split by product $2.58M 100.00% | $2.58M |
| 2022-06-30 | Not split by product $2.34M 100.00% | $2.34M |
| 2022-03-31 | Not split by product $2.52M 100.00% | $2.52M |
| 2021-12-31 | Not split by product $2.55M 100.00% | $2.55M |
| 2021-09-30 | Not split by product $2.72M 100.00% | $2.72M |
| 2021-06-30 | Not split by product $2.90M 100.00% | $2.90M |
| 2021-03-31 | Not split by product $2.96M 100.00% | $2.96M |
| 2020-12-31 | Not split by product $2.72M 100.00% | $2.72M |
| 2020-09-30 | Not split by product $2.25M 100.00% | $2.25M |
| 2020-06-30 | Not split by product $1.50M 100.00% | $1.50M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |